login
login

Europe Daily Bulletin No. 11599

23 July 2016
Contents Publication in full By article 17 / 37
SECTORAL POLICIES / (ae) health
Move towards preventive use of Truvada in EU

Brussels, 22/07/2016 (Agence Europe) - The European Medicines Agency sees no objection to extending the marketing authorisation for Truvada. The Committee for Medicinal products for Human Use (CHMP) took the view on Thursday 21 July that this medicine could also be used as part of a prevention strategy.

The CHMP opinion will now be sent to the European Commission which has the final say on the matter.

Truvada is a medicine produced by American laboratory Gilead. It contains two active...

Contents

BREACHES OF EU LAW
COURT OF JUSTICE OF THE EU
SECTORAL POLICIES
ECONOMY - FINANCE
INSTITUTIONAL
EXTERNAL ACTION
COUNCIL OF EUROPE
NEWS BRIEFS
CALENDAR